BuzzFeed Inc
NASDAQ:BZFD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
B
|
BuzzFeed Inc
NASDAQ:BZFD
|
US |
|
Jagsonpal Pharmaceuticals Ltd
NSE:JAGSNPHARM
|
IN |
Balance Sheet
Balance Sheet Decomposition
BuzzFeed Inc
BuzzFeed Inc
Balance Sheet
BuzzFeed Inc
| Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | Dec-2025 | ||
|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||
| Cash & Cash Equivalents |
59
|
91
|
80
|
56
|
36
|
39
|
8
|
|
| Cash Equivalents |
59
|
91
|
80
|
56
|
36
|
39
|
8
|
|
| Total Receivables |
100
|
106
|
143
|
116
|
76
|
53
|
46
|
|
| Accounts Receivables |
100
|
106
|
143
|
116
|
76
|
53
|
46
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
12
|
12
|
29
|
26
|
21
|
9
|
32
|
|
| Total Current Assets |
170
|
209
|
252
|
199
|
133
|
101
|
86
|
|
| PP&E Net |
30
|
26
|
23
|
84
|
59
|
35
|
28
|
|
| PP&E Gross |
30
|
26
|
23
|
84
|
59
|
35
|
28
|
|
| Accumulated Depreciation |
38
|
38
|
36
|
45
|
45
|
48
|
50
|
|
| Intangible Assets |
16
|
17
|
153
|
141
|
49
|
34
|
54
|
|
| Goodwill |
0
|
0
|
195
|
92
|
58
|
43
|
13
|
|
| Other Long-Term Assets |
29
|
29
|
15
|
15
|
114
|
8
|
8
|
|
| Other Assets |
0
|
0
|
195
|
92
|
58
|
43
|
13
|
|
| Total Assets |
245
N/A
|
279
+14%
|
637
+128%
|
530
-17%
|
411
-22%
|
221
-46%
|
188
-15%
|
|
| Liabilities | ||||||||
| Accounts Payable |
10
|
8
|
16
|
29
|
46
|
14
|
20
|
|
| Accrued Liabilities |
37
|
40
|
69
|
81
|
50
|
53
|
33
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
125
|
26
|
31
|
|
| Other Current Liabilities |
5
|
8
|
9
|
13
|
6
|
4
|
12
|
|
| Total Current Liabilities |
52
|
57
|
94
|
123
|
228
|
97
|
95
|
|
| Long-Term Debt |
0
|
20
|
142
|
152
|
34
|
0
|
28
|
|
| Deferred Income Tax |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Minority Interest |
0
|
1
|
4
|
3
|
2
|
2
|
1
|
|
| Other Liabilities |
22
|
20
|
26
|
60
|
39
|
18
|
15
|
|
| Total Liabilities |
74
N/A
|
98
+33%
|
267
+172%
|
339
+27%
|
303
-11%
|
117
-61%
|
139
+19%
|
|
| Equity | ||||||||
| Common Stock |
495
|
495
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
357
|
347
|
322
|
523
|
612
|
622
|
680
|
|
| Additional Paid In Capital |
36
|
37
|
696
|
716
|
723
|
730
|
736
|
|
| Treasury Stock |
1
|
1
|
0
|
0
|
0
|
0
|
3
|
|
| Other Equity |
1
|
3
|
3
|
2
|
3
|
4
|
4
|
|
| Total Equity |
171
N/A
|
181
+6%
|
371
+105%
|
191
-48%
|
109
-43%
|
105
-4%
|
49
-53%
|
|
| Total Liabilities & Equity |
245
N/A
|
279
+14%
|
637
+128%
|
530
-17%
|
411
-22%
|
221
-46%
|
188
-15%
|
|
| Shares Outstanding | ||||||||
| Common Shares Outstanding |
50
|
50
|
48
|
35
|
36
|
38
|
37
|
|